Related Experiment Video
Updated: May 10, 2026
09:24
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Bio-hybrid tissue engineering for cellular cardiomyoplasty: future directions
1Department of Cardiovascular Surgery and Laboratory of Biosurgical Research, Pompidou Hospital, University of Paris Descartes, Paris, France.
Methods in Molecular Biology (Clifton, N.J.)
|June 29, 2013
Summary
Cardiomyopathy alters heart ventricle shape, leading to heart failure. Myocardial tissue engineering with stem cells offers a promising new treatment for this condition.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Regenerative Medicine
Background:
- Cardiomyopathy causes ventricular geometric alteration, shifting from an elliptical to a spherical shape.
- Ventricular chamber dilatation and spherical deformation are significant contributors to morbidity and mortality in congestive heart failure.
- Diastolic dysfunction is a major clinical challenge in heart failure due to limited treatment options.
Purpose of the Study:
- To explore myocardial tissue engineering with stem cells as a novel therapeutic approach for heart failure.
- To address the unmet need for specific treatments for diastolic dysfunction in cardiomyopathy patients.
Main Methods:
- Investigating the potential of stem cell-associated myocardial tissue engineering.
- Focusing on geometric remodeling and functional recovery of the cardiac ventricle.
Main Results:
- Myocardial tissue engineering with stem cells shows promise for treating heart failure.
- This approach offers a potential solution for ventricular remodeling and diastolic dysfunction.
Conclusions:
- Stem cell-based myocardial tissue engineering represents a new therapeutic avenue for heart failure.
- This innovative strategy provides hope for patients with cardiomyopathy and congestive heart failure.
